Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The FDA does not approve this compound for human use, and long-term data are still evolving
Tirzepatide acts as a dual agonist for GLP-1 and GIP receptors, encouraging insulin release and reducing appetite, which aids in body mass management
The early success of these drugs in combating what was considered to be an intractable public health concern has begun to reshape how society is framing obesity as a health issue, leading to ripple effects that are affecting how food is sold and consumed, insurance and workplace wellness policies, and importantly, public attitudes surrounding the veracity of framing obesity as a medical issue that can and should be treated
"Ozempic has become a leading, trusted brand for people with type 2 diabetes and the science is deep
At 5 mg/mL: 50 units = 2.5 mg This is the lowest concentration commonly available
